Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ASTRAZENECA Latest News

12 HOURS AGO - TheStreet

A Must Read - Share

ASCO '15: Merck, Bristol Drugs Boost Immune System to Kill Broad Swath of Cancer Types

CHICAGO (TheStreet) -- Four clinical trials involving the checkpoint inhibitors from Merck MRK and Bristol-Myers Squibb are showing promising signs of efficacy in a wide range of solid tumors, according to results unveiled for the first time Friday at the start of the American Society of Clinical Oncology (ASCO) annual meeting. The class of cancer immunotherapy drugs which target the ...

Tags: ASCO '15: Merck, Bristol Drugs Boost Immune System to Kill Broad Swath of Cancer Types,  Astrazeneca Latest News

12 HOURS AGO - TheStreet

A Must Read - Share

Fly Watch: Several Names That May Move Following ASCO Meeting

NEW YORK (TheStreet) -- The American Society of Clinical Oncology, or ASCO, is holding the society's 51st annual meeting from May 29 to June 2 in Chicago, Illinois. In advance of the meeting, analysts at Mizuho and FBR & Co. highlighted several companies they believe will provide clinical updates that may move their respective shares. BACKGROUND: After the market close ...

Tags: Fly Watch: Several Names That May Move Following ASCO Meeting,  Astrazeneca Latest News

14 HOURS AGO - TheStreet

A Must Read - Share

Jim Cramer's Stop Trading: Lilly's AstraZeneca Partnership Is a ‘Brilliant’ Move

NEW YORK (TheStreet) -- "It never stops innovating," said TheStreet's Jim Cramer about Eli Lilly & Co.  during CNBC's "Stop Trading" segment Friday. "We don't talk enough about it."  Cramer was referring to the drug maker's decision to partner with AstraZeneca PLC  to test a new cancer drug combination. Must Read: 7 Stocks Warren Buffett Is Buying in 2015 According to ...

Tags: Jim Cramer's Stop Trading: Lilly's AstraZeneca Partnership Is a ‘Brilliant’ Move,  Astrazeneca Latest News

MAY 28, 2015 - Forbes

A Must Read - Share

Why Pfizer's Pursuit Of AstraZeneca Continues To Shape The Outlook Of Both Companies

A year on from Pfizer abandoning its bid to acquire AstraZeneca and the UK drugmaker has received a timely reminder that touting an impressive R&D pipeline is a far cry from delivering innovative new products to the market.

Tags: Why Pfizer's Pursuit Of AstraZeneca Continues To Shape The Outlook Of Both Companies,  Astrazeneca Latest News

MAY 27, 2015 - Benzinga

A Must Read - Share

CNBC's Stock Pops & Drops From May 26

On CNBC's Stock Pops & Drops, Karen Finerman explained that AstraZeneca plc (ADR) (NYSE: AZN) dropped 2.55 percent on the news that Amgen, Inc.(NASDAQ: AMGN) is going to leave their partnership for brodalumab dr

Tags: CNBC's Stock Pops & Drops From May 26,  Astrazeneca Latest News